Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-07

Clinical Trial Update: Dexmedetomidine Infusion as an Analgesic Adjuvant During Laparoscopic Cholecystectomy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating dexmedetomidine infusion as an analgesic adjuvant to reduce postoperative pain after laparoscopic cholecystectomy, with stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Precedex) (dexmedetomidine)

Snippet

Sponsor: Bogomolets National Medical University | Conditions: Pain, Postoperative | Phase 3 | Status: UNKNOWN